231 related articles for article (PubMed ID: 30603598)
1. Refractory diffuse alveolar hemorrhage caused by eosinophilic granulomatosis with polyangiitis in the absence of elevated biomarkers treated successfully by rituximab and mepolizumab: A case report.
Shiroshita A; Nakashima K; Motojima S; Aoshima M
Respir Med Case Rep; 2019; 26():112-114. PubMed ID: 30603598
[TBL] [Abstract][Full Text] [Related]
2. Rituximab and mepolizumab combination therapy for glucocorticoid-resistant myocarditis related to eosinophilic granulomatosis with polyangiitis.
Higashitani K; Yoshimi R; Sato Y; Watanabe T; Ihata A
Mod Rheumatol Case Rep; 2022 Jan; 6(1):87-92. PubMed ID: 34473835
[TBL] [Abstract][Full Text] [Related]
3. Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis.
Thiel J; Troilo A; Salzer U; Schleyer T; Halmschlag K; Rizzi M; Frede N; Venhoff A; Voll RE; Venhoff N
J Allergy Clin Immunol Pract; 2017; 5(6):1556-1563. PubMed ID: 28916432
[TBL] [Abstract][Full Text] [Related]
4. An overlap of granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis.
Surendran S; Gundappa C; Gandhi A; Kurien AA; Fernando E
Saudi J Kidney Dis Transpl; 2017; 28(3):639-644. PubMed ID: 28540906
[TBL] [Abstract][Full Text] [Related]
5. Improvement of Chronic Rhinosinusitis and Reduction of the Myeloperoxidase-Antineutrophil Cytoplasmic Antibody Titer in a Patient with Eosinophilic Granulomatosis with Polyangiitis by Additional Mepolizumab.
Tamechika SY; Isogai S; Maeda S; Naniwa T; Niimi A
Case Rep Rheumatol; 2021; 2021():5561762. PubMed ID: 33859858
[TBL] [Abstract][Full Text] [Related]
6. Successful Treatment of Eosinophilic Granulomatosis With Polyangiitis: A Case of Refractory Peripheral Neuropathy and Comorbid Chronic Progressive Pulmonary Aspergillosis Treated With Mepolizumab.
Sekiya R; Soma T; Nakagome K; Nagata M
Cureus; 2024 Jan; 16(1):e52192. PubMed ID: 38222984
[TBL] [Abstract][Full Text] [Related]
7. Improvement of peripheral neuropathy in a patient with antineutrophil cytoplasmic antibody-negative eosinophilic granulomatosis with polyangiitis by additional mepolizumab.
Kai Y; Yoshikawa M; Matsuda M; Suzuki K; Ohara H; Iguchi N; Kasamatsu T; Uno K; Fujioka N; Fujita Y; Muro S
Allergy Asthma Clin Immunol; 2022 Feb; 18(1):14. PubMed ID: 35183225
[TBL] [Abstract][Full Text] [Related]
8. A case of subarachnoid haemorrhage associated with MPO-ANCA-positive eosinophilic granulomatosis with polyangiitis, successfully treated with glucocorticoid, cyclophosphamide, and mepolizumab.
Satake Y; Sakai S; Takao T; Saeki T
Mod Rheumatol Case Rep; 2023 Dec; ():. PubMed ID: 38109745
[TBL] [Abstract][Full Text] [Related]
9. Concurrent Use of Mepolizumab and Rituximab for Eosinophilic Granulomatosis With Polyangiitis and Multisystem Involvement.
Afiari A; Gabriel A; Gaiki MR
Cureus; 2020 Jul; 12(7):e9242. PubMed ID: 32821588
[TBL] [Abstract][Full Text] [Related]
10. Targeted immunotherapy strategies in ANCA-associated vasculitis.
Puéchal X
Joint Bone Spine; 2019 May; 86(3):321-326. PubMed ID: 30201478
[TBL] [Abstract][Full Text] [Related]
11. Effective treatment with mepolizumab in a patient with severe eosinophilic granulomatosis with polyangiitis complicated with small intestine perforation.
Sato M; Yatomi M; Wakamatsu I; Uno S; Hanazato C; Masuda T; Yamaguchi K; Aoki-Saito H; Kasahara N; Miura Y; Tsurumaki H; Hara K; Koga Y; Sunaga N; Okada T; Ikota H; Hisada T; Maeno T
Respir Med Case Rep; 2023; 43():101818. PubMed ID: 36950026
[TBL] [Abstract][Full Text] [Related]
12. Early add-on administration of mepolizumab and intravenous immunoglobulin effective in treating eosinophilic granulomatosis with polyangiitis.
Ikeda T; Komatsu T; Yokoyama K; Takahashi K; Kawakami T
J Dermatol; 2021 Apr; 48(4):529-532. PubMed ID: 33305381
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of clinical benefit from treatment with mepolizumab for patients with eosinophilic granulomatosis with polyangiitis.
Steinfeld J; Bradford ES; Brown J; Mallett S; Yancey SW; Akuthota P; Cid MC; Gleich GJ; Jayne D; Khoury P; Langford CA; Merkel PA; Moosig F; Specks U; Weller PF; Wechsler ME
J Allergy Clin Immunol; 2019 Jun; 143(6):2170-2177. PubMed ID: 30578883
[TBL] [Abstract][Full Text] [Related]
14. A Pediatric Case of Relapsing Eosinophilic Granulomatosis with Polyangiitis Successfully Treated with Mepolizumab.
Nara M; Saito M; Abe F; Komatsuda A; Wakui H; Takahashi N
Intern Med; 2019 Dec; 58(24):3583-3587. PubMed ID: 31391393
[TBL] [Abstract][Full Text] [Related]
15. Mepolizumab for the treatment of eosinophilic granulomatosis with polyangiitis.
Ennis D; Lee JK; Pagnoux C
Expert Opin Biol Ther; 2019 Jul; 19(7):617-630. PubMed ID: 31146595
[TBL] [Abstract][Full Text] [Related]
16. Benralizumab monotherapy was insufficient to induce remission in patients with active eosinophilic granulomatosis with polyangiitis.
Matsuno O; Minamoto S
Respir Med Case Rep; 2022; 40():101763. PubMed ID: 36353062
[TBL] [Abstract][Full Text] [Related]
17. Eosinophilic Granulomatosis With Polyangiitis Presenting With Oral Granuloma as the Initial Symptom: A Case Report.
Lin L; Yu R; Zheng L; Gong S; Yang J
Front Med (Lausanne); 2022; 9():842137. PubMed ID: 35620723
[TBL] [Abstract][Full Text] [Related]
18. Clinical Features of Patients with Active Eosinophilic Granulomatosis with Polyangiitis Successfully Treated with Mepolizumab.
Tsurikisawa N; Oshikata C; Watanabe M; Fukuda N; Yamaguchi T; Kiyohara H; Kaneko T
Int Arch Allergy Immunol; 2021; 182(8):744-756. PubMed ID: 33887721
[TBL] [Abstract][Full Text] [Related]
19. Eosinophilic granulomatosis with polyangiitis: sequential use of mepolizumab following rituximab for inadequate asthma control despite vasculitis remission.
Cremonezi Lammoglia B; De Aguiar Trevise L; Paslar Leal T; Pereira Lopes Vieira Pinto M; Hasselmann G; Salles Rosa Neto N
Reumatismo; 2023 Dec; 75(4):. PubMed ID: 38115776
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of eosinophilic granulomatosis with polyangiitis (EGPA; formerly Churg-Strauss syndrome) with rituximab in a case refractory to glucocorticoids, cyclophosphamide, and IVIG.
Umezawa N; Kohsaka H; Nanki T; Watanabe K; Tanaka M; Shane PY; Miyasaka N
Mod Rheumatol; 2014 Jul; 24(4):685-7. PubMed ID: 24517553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
